Literature DB >> 35371732

Stillbirth in COVID-19 Affected Pregnancies: A Double Whammy for the Mother.

Sheeba Marwah1, Ankita Jain1, Anjali Dabral1, Nitesh Gupta2.   

Abstract

Introduction Pregnant women represent a high-risk group especially during the COVID-19 pandemic, suffering at the expense of pandemic restrictions and landing up in adverse maternofetal outcomes including stillbirth. Fetal demise along with COVID-19 disease acts as a double blow to these mothers. Literature is still limited on its impact on maternofetal outcomes. Methods A prospective, observational study was conducted in a tertiary care hospital in Delhi, India from April 15, 2020 to April 14, 2021, wherein all pregnant mothers with SARS-CoV-2 infection in the hospital who delivered a stillborn baby were enrolled and analyzed for incidence of stillbirth. These women were evaluated for risk factors and causes for stillbirth. Results Out of 15859 deliveries in the institute, there were 330 viable births among COVID-19 affected pregnancies. The incidence of stillbirth was 7.2% (24/330). The institutional delivery rate fell by 43% during the pandemic. The majority of cases were unbooked, from rural areas and of low socioeconomic status (p<0.01). The most significant risk factor and cause for stillbirth was an associated comorbidity (75%, p<0.001), notably severe forms of hypertensive disorders of pregnancy (HDP, 41.6%, p=0.002), followed by preterm labour (58.3%) and preterm premature rupture of membranes (PPROM, 29.1%, p<0.001). HDP remained the main cause of macerated stillbirths while maternal fever (50%, p<0.001) was the main cause of fresh stillbirth. Major modifiable factors were lack of awareness of when to seek care (83.3%), financial reasons (75%), commutation problems (87.5%), distance to hospitals (50%) and delayed referral (41.6%). Conclusion Improved policy-making, with an emphasis on telemedicine, COVID-19 preparedness alongside amped up vaccination and healthcare workers training will help reduce adverse maternofetal outcomes.
Copyright © 2022, Marwah et al.

Entities:  

Keywords:  adverse outcomes of sars-cov-2; care of covid-19 affected pregnancies; covid-19 in pregnancy; maternofetal outcomes in covid-19; stillbirth; stillbirth in covid-19

Year:  2022        PMID: 35371732      PMCID: PMC8938211          DOI: 10.7759/cureus.22396

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

A novel Coronavirus identified as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) hit the world towards the end of 2019, causing a respiratory illness called coronavirus disease-19 (COVID-19). The disease evolved as an epidemic in China and then progressed to spread worldwide rapidly, declared as a pandemic on March 11, 2020 [1,2]. To date, COVID-19 has affected about 153 million people globally, with around 3.2 million deaths [3]. Likewise in India, there have been 20.2 million cases and 221,000 deaths thus far [1,3]. Owing to the unknown behaviour of SARS-CoV-2 and the immense magnitude of the COVID-19 outbreak, rigorous containment measures were adopted by governments all over the world to reduce its spread and detrimental effects on healthcare [1,4]. This included national/local lockdowns to restrict public movement to curtail the spread of the disease. This brought unprecedented changes in the landscape of medical services, access and care [5]. Subsequently, healthcare facilities saw a decrease in the outpatient attendance and admission numbers, largely due to fear of contracting the infection while seeking a doctor amidst the backdrop of imposed travel restrictions. This has been disrupting the access and delivery of healthcare services, including maternal and newborn care, especially in low-resource countries [6]. Research has shown that a reduction of 10% in mother and child healthcare coverage even in non-COVID times could result in an excess of 28,000 maternal deaths and 168,000 neonatal deaths worldwide, as was seen during Ebola virus outbreaks in 2014-16 in West Africa [7,8]. Similarly, a model-based study spanning 118 countries to gauge the access to health services during the COVID-19 outbreak reinforced the importance of continuum of care [9]. The improvement that India has shown in institutional delivery and maternal-neonatal mortality over the past decade, is at risk now [10,11]. Also, a high proportion of the rural population coupled with illiteracy has led to the fear, stigma, and superstitions related to COVID-19. There is a dearth of studies related to the impact of COVID-19 on maternal and perinatal outcomes, especially in low resource countries like India. Stillbirth on the other hand leaves the couple destitute and with unimaginable sorrow. These bereaving parents constitute a high-risk group for potential long-lasting psychological sequelae. Battling COVID-19 physically and socially along with a fetal loss imposes grief which is unfathomable. This delicate situation calls for simultaneous empathy and adept addressal of medical concerns of SARS-CoV-2 positive mothers from the healthcare professionals. The present study was undertaken to determine the incidence of stillbirths in COVID-19 affected pregnancies, and to ascertain the risk factors and causes of stillbirth in the same. This will guide the budding clinicians with comprehensive management of such women to avert perinatal morbidity. It will also aid in formulating standard national protocols for the same, which could be instrumental in devising preventive strategies for obtaining optimal fetal outcome.

Materials and methods

This was a prospective, observational study conducted in the department of Obstetrics and Gynecology in a tertiary care hospital, New Delhi, India from April 15, 2020 till April 14, 2021, wherein all admitted SARS-CoV-2 positive women with intrauterine fetal demise (IUD) were enrolled in the study, after taking an informed consent from all study participants. All procedures performed in the study involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical clearance was obtained from Institutional Ethics Committee, VMMC and Safdarjung hospital dated 6/04/2020 reference no. IEC/VMMC/SJH/Project/2020-04/CC-04. Any woman having an intrapartum stillbirth was also included in the study, however, women with IUD who succumbed to COVID-19 disease antenatally were excluded from the study. For study purposes, a confirmed case of COVID-19 irrespective of symptoms was defined as a positive result on real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of naso-oropharyngeal swab specimens or a positive rapid antigen test (RAT) [12]. Stillbirth was defined as a baby born with no signs of life after 22 weeks of gestation [13]. History was taken and examination was done to evaluate for risk factors and causes for stillbirth. The couple was appropriately counselled regarding the outcome and managed as per the institutional protocol, besides treating the cause if any. All patients were followed up till discharge. The presentation of the categorical variables was done in the form of numbers and percentages (%). On the other hand, the quantitative data were presented as the mean ± SD and as median with 25th and 75th percentiles (interquartile range). The data normality was checked by using Kolmogorov-Smirnov test. The cases in which the data was not normal, non-parametric tests were used. The comparison of the variables which were qualitative in nature was analyzed using the Chi-Square test. If any cell had an expected value of less than 5 then Fisher’s exact test was used. The data entry was done in the Microsoft EXCEL (Microsoft® Corp., Redmond, WA, USA) spreadsheet and the final analysis was done with the use of Statistical Package for Social Sciences (SPSS) software, version 21.0 (IBM Corp., Armonk, NY, USA). Chi-square test was applied, keeping null hypothesis value of 15% for risk factors, clinical profile, and possible modifiable factors. For statistical significance, a p-value of less than 0.05 was considered statistically significant.

Results

During the study period, 15859 deliveries occurred in the department. There were 402 SARS-CoV-2 positive women admitted in the department and 330 viable births among them. The incidence of stillbirth was 24 out of 330 (7.2%). All of these 24 patients consented to participate in the study. Most study participants were 21-33 years old/average being 25.5 years (p-value<0.001). The majority (75%) of the mothers belonged to rural areas and lower socioeconomic status (p-value<0.01) (Table 1).
Table 1

Sociodemographic and maternal characteristics of study participants

n = number of participants, max. - maximum

Baseline characteristics and demographic variablesn (max. 24), (%)AverageP-value
Age (years)   25.5 < 0.001 
<30 20 (83.3)   
30-60 4 (16.6)   
Booking status   < 0.001 
Unbooked 18 (75.0)   
Booked 6 (25.0)   
Residence   0.014 
Rural 18 (75.0)   
Urban 6 (25.0)   
Socioeconomic status (Modified Kuppuswamy)   <0.001 
Upper-middle 2 (8.3)   
Lower-middle 6 (25.0)   
Upper-lower 12 (50.0)   
Lower 4 (16.6)   
Parity  1.41 0.802 
Nulliparous 8 (33.3)   
Primiparous 8 (33.3)   
Para 2-4 8 (33.3)   

Sociodemographic and maternal characteristics of study participants

n = number of participants, max. - maximum The most significant risk factor for stillbirth was an associated comorbidity (75%, p<0.001). The most notable comorbidity was severe forms of hypertensive disorders in pregnancy (HDP) (41.6% cases), nine having severe preeclampsia, out of which four had HELLP syndrome (haemolysis, elevated liver enzymes and low platelets), and one patient had antepartum eclampsia (p=0.002). This was followed by preterm labour seen in nearly half of the mothers (p<0.05), while almost a third were associated with preterm premature rupture of membranes (PPROM, p<0.001). There was only one unexplained case in which no cause was found. Birth defects were not seen in any case (Tables 2, 3).
Table 2

Risk factors and causes for stillbirth

n - number of participants, max. - maximum, PPROM - preterm premature rupture of membranes

*With/without chronic hypertension

Risk factors and causes for stillbirth n (max. 24), (%) P-value 
MATERNAL FACTORS   
Obstetric complications   
Preterm labour 14 (58.3) <0.001 
PPROM 7 (29.1) <0.001 
Chorioamnionitis 2 (8.3) 0.125 
Postdatism 2 (8.3) 0.361 
Associated medical comorbidity 18 (75%) <0.001 
Hypertensive disorders* 10 (41.6) 0.002 
           Severe preeclampsia  
           Antepartum eclampsia  
Maternal anaemia (severe) 5 (20.8) 0.423 
Maternal jaundice 2 (8.3) 0.124 
Gestational diabetes 2 (8.3) 0.351 
FETAL FACTORS   
Fetal distress 4 (16.6) 0.819 
Meconium-stained liquor 2 (8.3) 0.360 
UNEXPLAINED 1 (4.1) 0.783 
Table 3

Application of the ICD-PM classification to determine causes of stillbirth

n - number of participants

Causes of stillbirth M1 Complications of placenta, cord, etc. M2 Maternal complications of pregnancy M3 other complications of labour & delivery M4 Maternal medical & surgical conditions M5 No maternal condition Total
ANTEPARTUM DEATH 
A1: Congenital malformations, and chromosomal abnormalities 
A2: Infection 
A3: Antepartum hypoxia 12 13 
A4: Other specified antepartum disorder 
A5: Disorder related to fetal growth 
A6: Antepartum death of unspecified cause 
n12 22 
INTRAPARTUM DEATH 
I1: Congenital malformations, and chromosomal abnormalities 
I2: Birth trauma 
I3: Acute intrapartum event 
I4: Infection 
I5: Other specified intrapartum event 
I6: Disorder related to fetal growth 
I7: Intrapartum of unspecified cause 
n
Total12 24 

Risk factors and causes for stillbirth

n - number of participants, max. - maximum, PPROM - preterm premature rupture of membranes *With/without chronic hypertension

Application of the ICD-PM classification to determine causes of stillbirth

n - number of participants COVID-19 symptoms were present in half of the women, such as high-grade fever (50%), followed by cough (25%) and shortness of breath (4.1%, p<0.001). These women presented at a mean gestation of 35.2 weeks with 10 delivering at term and 14 preterm deliveries. Prior history of miscarriages was noted in two (4.15%) patients; also 25% of patients had a bad obstetric history. The majority (83.3%) of patients delivered vaginally out of which half were preterm vaginal deliveries and half delivered at term. Four cases were, however, delivered by emergency caesarean section because of maternal/fetal indications. A total of 66.6% of these babies were males. Macerated stillbirth, seen in 50% of women, was observed in medical comorbidities like severe HDP, maternal anemia, and jaundice. Only two of these were seen in chorioamnionitis. On the other hand, fresh stillbirths were seen mostly in maternal infection. None of the stillbirths had congenital malformation diagnosed antenatally or noted after delivery (Table 4).
Table 4

Clinical profile of study participants and course in the hospital

n - number of participants, max. - maximum, SB - stillbirth, BW - birth weight, kg - kilogram, ICU - intensive care unit

Clinical characteristics n (max. 24), (%) Average P-value
MATERNAL PROFILE 
COVID-19 presenting symptoms   < 0.001 
Asymptomatic 12 (50.0)   
Symptomatic 12 (50.0)   
High-grade fever 12   
Cough   
Shortness of breath   
Period of Gestation (weeks)  35.2 <0.001 
Mode of Delivery   0.819 
Vaginal 20 (83.3)   
Caesarean 4 (16.6)   
Maternal outcome   0.456 
Need for ICU care 3 (12.5)    
Mortality 1 (4.1)   
STILLBIRTH (SB) DETAILS 
Time   0.732 
Antepartum SB 22 (91.6)   
Intrapartum SB 2 (9.09)   
Type of SB   0.832 
Fresh 12 (50.0)   
Macerated 12 (50.0)   
Birthweight (BW) (kg)  2.16 <0.001 
Normal BW (2.5 to <4.0) 9 (37.5)   
Low BW (1.5 to <2.5 kg) 8 (33.3)   
Very Low BW (1 to <1.5 kg) 6 (25.0)   
Extremely Low BW (<1 kg) 1 (4.1)   
Sex   0.102 
Boy 16 (66.6)   
Girl 8 (33.3)   

Clinical profile of study participants and course in the hospital

n - number of participants, max. - maximum, SB - stillbirth, BW - birth weight, kg - kilogram, ICU - intensive care unit Major factors contributing to the ‘delay’ as per the ‘Three-Delays Model’ were: (a) delay in seeking care due to poor understanding of the complications and when to seek care (83.3%), financial reasons (75%) or lower status of women (66.6%); (b) delay in reaching care as a result of travel cost and availability (87.5%), distance to hospitals (50%) and (c) delay in receiving care as a result of delayed referral (41.6%) (Table 5).
Table 5

Application of three-delays model to understand modifiable factors contributing to stillbirth

n - number of participants, max. - maximum

Factor n (max. 24) 
Delay in decision to seek care 
The low status of women 16 66.6% 
Poor understanding of complications and risk factors in pregnancy and when to seek medical help 20 83.3% 
Previous poor experience of health care 8.3% 
Perceived poor quality of care at the healthcare facility 12.5% 
Avoiding admission and long stay at a healthcare facility 33.3% 
Financial implications 18 75% 
Delay in reaching care 
Distance to health centres and hospitals 12 50% 
Availability of and cost of transportation 21 87.5% 
Poor roads and infrastructure 8.3% 
Visited a traditional healer or traditional birth attendant first 12.5% 
Delay in receiving adequate health care 
Inadequate referral systems 10 41.6% 
Poor facilities and lack of medical supplies 4.1% 

Application of three-delays model to understand modifiable factors contributing to stillbirth

n - number of participants, max. - maximum

Discussion

This was one of the earliest studies done to estimate the incidence of stillbirth in COVID-19 pregnancies. The total number of deliveries was 15859 over a period of one year in the present study, which is quite low, as compared to the delivery rate of 26,213 reported by the institute [14]. Hence, the institutional birth was reduced by 43% during the study period which is similar to a study conducted by the World Association of Perinatal Medicine (WAPM) showing a 49% decrease in institutional birth during the current pandemic [15]. This decline can be explained by more high-risk referral to our tertiary care hospital and filtering of low-risk pregnancies which got delivered at a center close to their residence, or at home, owing to fear of visiting a hospital as well as travel restrictions. The stillbirth rate (SBR) in the pregnancies affected by SARS-CoV-2 infection was 7.2% in the present study which is way too high when compared to SBR of 2.9% in the state of Delhi and that of 2.1% reported in low-middle income countries in pre-pandemic times [16,17]. In another study by the same authors, the SBR was reported to be 2.7% in the institute before the pandemic which can be elucidated by the increase in high-risk referral to our hospital being a tertiary care institute [14]. Our findings are akin to a study in Nepal which reported almost doubling of the institutional SBR during the COVID-19 pandemic from the pre-pandemic value [11]. A recent study in the UK realized a four-fold hike in SBR (1.6%) [18]. A meta-analysis showed that there was a significant elevation in SBR during the pandemic worldwide, the most significant increases being in low-middle income countries [19]. In contrast, a Swedish study revealed no difference in SBR during the pandemic [20]. The above findings can be construed as a result of the modification in the antenatal schedule due to COVID-19 exposure, women returning for routine antenatal check-ups at longer gaps while a subset of these preferred to stay at home and reported to the hospital only during emergency. There was an amendment in obstetric care protocol warranting examination only when indicated and delay in ultrasound examination especially in pregnancies with SARS-CoV-2 positive status. Furthermore, these patients were too stressed out to keep a tab on daily fetal kick count, as a result, fetal distress was missed with around half of the mothers presenting with IUD at the time of admission to our institute. Aforesaid observations were further augmented by the majority of patients being unbooked, hailing from rural areas and being referred. Apart from fear and initial restriction to travel, illiteracy, lack of awareness and poor adherence to antenatal schedule were quite prevalent in the study population. As is evident from past literature, this consortium of women is more prone to infection. The main causes of stillbirth seen in the current study were preterm labour with/without PPROM and severe forms of hypertensive disorders of pregnancy (HDP). In the present study, half of the patients presented with fever at the time of admission. Literature has shown that maternal infection, fever and inflammation, all of which are at play in COVID-19 disease, leading to the release of pro-inflammatory cytokines such as interleukin-1 and tumor necrosis factor-alpha which play a role in stimulating prostaglandin production by human amnion and decidua leading to a cascade of events resulting in labour and/or rupture of membranes, and hence preterm delivery [21,22]. Furthermore, the distress of COVID-19-related social restrictions, besides psychosocial stress during pregnancy, adds to preterm delivery and birth rate [23]. Although there is still a paucity of adequate literature on this, the early studies done in Southeast Asia and the West along with a meta-analysis are consistent with increased incidence of preterm labour and delivery in COVID-19-affected pregnancies [11,15,24]. As such, the role of preterm labour as a cause for stillbirth was little if women presented to the hospital on time [14,15,24]. The adverse fetal outcomes were seen in women presenting late to the hospital, those not returning to OPD for regular check-ups, association with other medical diseases and women with acute hypoxia needing oxygen/ventilatory support. Three-quarters of the women had an associated medical disorder of which the most significant were severe forms of pregnancy-related hypertensive disorders. This re-emphasizes the felt need that the patients came to the hospital only in case of emergency. The high incidence of HDP in COVID-19-affected pregnancies is similar to the meta-analysis done in the West, which highlights the importance of regular blood pressure (BP) monitoring [18,19,24]. Hypertension is one of the factors in the triad of maternal mortality and a big preventable cause, wherein the role of continuous home care and BP monitoring at home cannot be over-emphasized. Hospital visits were deferred due to fear and other social factors, thus, presenting to the obstetrics emergency only on the development of severe features of preeclampsia. Severe preeclampsia not only aggravates but also mimics features of COVID-19 like headache, cough and shortness of breath, which only causes further delay in diagnosis [25,26]. This highlights that preeclampsia should be picked up early for timely intervention, and in times like these, the role of telemedicine and home BP monitoring play a crucial role. It is imperative for healthcare workers to counsel all patients at the point of first contact itself regarding the importance of timely reporting to the hospital. The case-based danger signs should be explained to all pregnant women when they come to the hospital and they should also be briefed about how, when and where they can access immediate care. The policymakers need to incorporate telemedicine as a part of institutional management protocol to increase the outreach of medical care. As per the three delays of care model, the reasons cited for the delay in seeking care were lack of awareness of the facilities that dealt with COVID-19 cases, hesitation to travel, social stigma or inability to get investigated locally at a nearby center [27]. Thus, as a result, there was delay in anticipating the complications, missing out on fetal distress and delay in management, causing grave outcomes in HDP. Obstetric triage during the pandemic is even more essential to know which patients need admission, and more importantly which don’t, considering limited hospital personnel working in staggering shifts, but at the same time not compromising with patient care or outcome [28]. Though no delay was noted at the level of healthcare institute in the present study but such delays have been quoted in recent studies [11,15,19]. Delayed referral and poor communication among various healthcare facilities need to be bolstered and augmented through nodal officers and local surveillance teams. A fetal loss in such a situation serves as a double blow to the COVID-mother who remains isolated as per government guidelines with only tele-connect. Need of the hour becomes empathizing with the patient and, thus, the role of healthcare provider and obstetrician gets further amplified in the prevention of stillbirths, finding the cause besides treating it, helping the family acclimatize and providing guided counselling to the bereaved family. Strengths and limitations This is a novel study estimating the incidence of stillbirth in COVID-afflicted pregnancies in India that includes cases over a period of one year and this magnitude of deliveries. However, a drawback of our study is the limited cases obtained as it’s a single centric study. The pandemic is still continuing, further research over a period of five years and multicentric data will help in knowing the actual impact of COVID-19 on pregnancy. Another limitation is that this being a facility-based study, the stillbirths occurring at home couldn’t be assessed, hence, collaboration with a public health specialist is recommended.

Conclusions

The incidence of stillbirth has soared in the present study owing to causes like severe HDP, preterm labour and PPROM. This necessitates early diagnosis, prompt isolation and initiation of care as per guidelines to address the risk factors for stillbirth and measures to avert intrauterine fetal hypoxia. India is currently overcoming the second wave of COVID-19. As we step up from ‘COVID to Co-WIN' with the ongoing vaccination drive in India, COVID preparedness for prevention and management of the third wave also needs to be reinforced. Standard operating procedures (SOPs) need to be laid down for standardizing the management of high-risk pregnancies with comorbidities in the setting of a pandemic to optimize care. Besides, we need to sensitize and train healthcare providers at the grass-root level regarding the latest protocols and appropriate counseling techniques for handling COVID mothers. People globally are experiencing anxiety, stigma, lockdown and chronic mental fatigue due to COVID-19. The establishment of post-COVID-care centers for managing its long-term sequelae as well as offering mental support and bereavement care is needed. Audiovisual and mass multimedia methods need to be utilized to sensitize the general public and expecting mothers about how to access healthcare services from home. Policymaking needs to be improved and healthcare systems need to be strengthened so as to deal with both the healthcare worker safety and patient needs.
  24 in total

1.  Psychosocial Implications of Stillborn Babies on Mother and Family: A Review from Tertiary Care Infirmary in India.

Authors:  Sheeba Marwah; Harsha Shailesh Gaikwad; Pratima Mittal
Journal:  J Obstet Gynaecol India       Date:  2018-09-06

2.  Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection.

Authors: 
Journal:  Ultrasound Obstet Gynecol       Date:  2021-01-21       Impact factor: 7.299

3.  Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19.

Authors:  Daniele Di Mascio; Cihat Sen; Gabriele Saccone; Alberto Galindo; Amos Grünebaum; Jun Yoshimatsu; Milan Stanojevic; Asım Kurjak; Frank Chervenak; María José Rodríguez Suárez; Zita Maria Gambacorti-Passerini; María de Los Angeles Anaya Baz; Esther Vanessa Aguilar Galán; Yolanda Cuñarro López; Juan Antonio De León Luis; Ignacio Cueto Hernández; Ignacio Herraiz; Cecilia Villalain; Roberta Venturella; Giuseppe Rizzo; Ilenia Mappa; Giovanni Gerosolima; Lars Hellmeyer; Josefine Königbauer; Giada Ameli; Tiziana Frusca; Nicola Volpe; Giovanni Battista Luca Schera; Stefania Fieni; Eutalia Esposito; Giuliana Simonazzi; Gaetana Di Donna; Aly Youssef; Anna Nunzia Della Gatta; Mariano Catello Di Donna; Vito Chiantera; Natalina Buono; Giulio Sozzi; Pantaleo Greco; Danila Morano; Beatrice Bianchi; Maria Giulia Lombana Marino; Federica Laraud; Arianna Ramone; Angelo Cagnacci; Fabio Barra; Claudio Gustavino; Simone Ferrero; Fabio Ghezzi; Antonella Cromi; Antonio Simone Laganà; Valentina Laurita Longo; Francesca Stollagli; Angelo Sirico; Antonio Lanzone; Lorenza Driul; Fabiana Cecchini D; Serena Xodo; Brian Rodriguez; Felipe Mercado-Olivares; Deena Elkafrawi; Giovanni Sisti; Rosanna Esposito; Antonio Coviello; Marco Cerbone; Maddalena Morlando; Antonio Schiattarella; Nicola Colacurci; Pasquale De Franciscis; Ilaria Cataneo; Marinella Lenzi; Fabrizio Sandri; Riccardo Buscemi; Giorgia Gattei; Francesca Della Sala; Eleonora Valori; Maria Cristina Rovellotti; Elisa Done; Gilles Faron; Leonardo Gucciardo; Valentina Esposito; Flaminia Vena; Antonella Giancotti; Roberto Brunelli; Ludovico Muzii; Luigi Nappi; Felice Sorrentino; Lorenzo Vasciaveo; Marco Liberati; Danilo Buca; Martina Leombroni; Francesca Di Sebastiano; Luciano Di Tizio; Diego Gazzolo; Massimo Franchi; Quintino Cesare Ianniciello; Simone Garzon; Giuliano Petriglia; Leonardo Borrello; Albaro Josè Nieto-Calvache; Juan Manuel Burgos-Luna; Caroline Kadji; Andrew Carlin; Elisa Bevilacqua; Marina Moucho; Pedro Viana Pinto; Rita Figueiredo; José Morales Roselló; Gabriela Loscalzo; Alicia Martinez-Varea; Vincente Diago; Jesús S Jimenez Lopez; Alicia Yeliz Aykanat; Stefano Cosma; Andrea Carosso; Chiara Benedetto; Amanda Bermejo; Otto Henrique May Feuerschuette; Ozlem Uyaniklar; Sakine Rahimli Ocakouglu; Zeliha Atak; Reyhan Gündüz; Esra Tustas Haberal; Bernd Froessler; Anupam Parange; Peter Palm; Igor Samardjiski; Chiara Taccaliti; Erhan Okuyan; George Daskalakis; Renato Augusto Moreira de Sa; Alejandro Pittaro; Maria Luisa Gonzalez-Duran; Ana Concheiro Guisan; Şerife Özlem Genç; Blanka Zlatohlávková; Anna Luengo Piqueras; Dolores Esteban Oliva; Aylin Pelin Cil; Olus Api; Panos Antsaklis; Liana Ples; Ioannis Kyvernitakis; Holger Maul; Marcel Malan; Albert Lila; Roberta Granese; Alfredo Ercoli; Giuseppe Zoccali; Andrea Villasco; Nicoletta Biglia; Ciuhodaru Madalina; Elena Costa; Caroline Daelemans; Axelle Pintiaux; Elisa Cueto; Eran Hadar; Sarah Dollinger; Noa A Brzezinski Sinai; Erasmo Huertas; Pedro Arango; Amadeo Sanchez; Javier Alfonso Schvartzman; Liviu Cojocaru; Sifa Turan; Ozhan Turan; Maria Carmela Di Dedda; Rebeca Garrote Molpeceres; Snezana Zdjelar; Tanja Premru-Srsen; Lilijana Kornhauser Cerar; Mirjam Druškovič; Valentina De Robertis; Vedran Stefanovic; Irmeli Nupponen; Kaisa Nelskylä; Zulfiya Khodjaeva; Ksenia A Gorina; Gennady T Sukhikh; Giuseppe Maria Maruotti; Silvia Visentin; Erich Cosmi; Jacopo Ferrari; Alessandra Gatti; Daniela Luvero; Roberto Angioli; Ludovica Puri; Marco Palumbo; Giusella D'Urso; Francesco Colaleo; Agnese Maria Chiara Rapisarda; Ilma Floriana Carbone; Antonio Mollo; Giovanni Nazzaro; Mariavittoria Locci; Maurizio Guida; Attilio Di Spiezio Sardo; Pierluigi Benedetti Panici; Vincenzo Berghella; Maria Elena Flacco; Lamberto Manzoli; Giuseppe Bifulco; Giovanni Scambia; Fulvio Zullo; Francesco D'Antonio
Journal:  J Perinat Med       Date:  2020-11-26       Impact factor: 1.901

4.  An Analysis of Cause of Stillbirth in a Tertiary Care Hospital of Delhi: A Contribution to the WHO SEARO Project.

Authors:  Abha Singh; Manisha Kumar
Journal:  J Obstet Gynaecol India       Date:  2018-08-10

5.  Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.

Authors:  Fernanda Tavares Da Silva; Bernard Gonik; Mark McMillan; Cheryl Keech; Stephanie Dellicour; Shraddha Bhange; Mihaela Tila; Diana M Harper; Charles Woods; Alison Tse Kawai; Sonali Kochhar; Flor M Munoz
Journal:  Vaccine       Date:  2016-07-16       Impact factor: 3.641

6.  COVID-19 susceptibility in pregnancy: Immune/inflammatory considerations, the role of placental ACE-2 and research considerations.

Authors:  Ann Kinga Malinowski; Abdelrahman Noureldin; Maha Othman
Journal:  Reprod Biol       Date:  2020-11-06       Impact factor: 2.376

7.  Successful Treatment of Preterm Labor in Association with Acute COVID-19 Infection.

Authors:  Paul C Browne; Jennifer B Linfert; Emilio Perez-Jorge
Journal:  Am J Perinatol       Date:  2020-04-24       Impact factor: 1.862

Review 8.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.

Authors:  Hussin A Rothan; Siddappa N Byrareddy
Journal:  J Autoimmun       Date:  2020-02-26       Impact factor: 7.094

9.  Coronavirus disease 2019 in pregnant women: a report based on 116 cases.

Authors:  Jie Yan; Juanjuan Guo; Cuifang Fan; Juan Juan; Xuechen Yu; Jiafu Li; Ling Feng; Chunyan Li; Huijun Chen; Yuan Qiao; Di Lei; Chen Wang; Guoping Xiong; Fengyi Xiao; Wencong He; Qiumei Pang; Xiaoling Hu; Suqing Wang; Dunjin Chen; Yuanzhen Zhang; Liona C Poon; Huixia Yang
Journal:  Am J Obstet Gynecol       Date:  2020-04-23       Impact factor: 10.693

10.  Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study.

Authors:  Ashish Kc; Rejina Gurung; Mary V Kinney; Avinash K Sunny; Md Moinuddin; Omkar Basnet; Prajwal Paudel; Pratiksha Bhattarai; Kalpana Subedi; Mahendra Prasad Shrestha; Joy E Lawn; Mats Målqvist
Journal:  Lancet Glob Health       Date:  2020-08-10       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.